blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1007676

EP1007676 - HIGH AFFINITY IMMUNOGLOBULIN E RECEPTOR-LIKE PROTEIN [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  28.01.2005
Database last updated on 20.09.2024
Most recent event   Tooltip28.01.2005Withdrawal of applicationpublished on 16.03.2005  [2005/11]
Applicant(s)For all designated states
INCYTE PHARMACEUTICALS, INC.
3174 Porter Drive
Palo Alto CA 94304 / US
[N/P]
Former [2000/24]For all designated states
INCYTE PHARMACEUTICALS, INC.
3174 Porter Drive
Palo Alto, CA 94304 / US
Inventor(s)01 / BANDMAN, Olga
366 Anna Avenue
Mountain View, CA 94043 / US
02 / LAL, Preeti
2382 Lass Drive
Santa Clara, CA 95054 / US
03 / CORLEY, Neil, C.
1240 Dale Avenue 30
Mountain View, CA 94040 / US
[2000/24]
Representative(s)Wright, Simon Mark, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2000/24]Wright, Simon Mark, et al
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date98943270.320.08.1998
[2000/24]
WO1998US17271
Priority number, dateUS1997091690221.08.1997         Original published format: US 916902
[2000/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9909170
Date:25.02.1999
Language:EN
[1999/08]
Type: A1 Application with search report 
No.:EP1007676
Date:14.06.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 25.02.1999 takes the place of the publication of the European patent application.
[2000/24]
Search report(s)International search report - published on:EP25.02.1999
ClassificationIPC:C12N15/12, C07K14/705, C12N15/70, C12N1/21, A61K38/17, C07K16/28, C12Q1/68
[2000/24]
CPC:
C07K14/70535 (EP,US); A61K38/00 (EP,US)
Designated contracting statesBE,   DE,   ES,   FR,   GB,   IT,   NL [2000/24]
TitleGerman:IMMUNGLOBULIN E-HOCHAFFINITÄTSREZEPTOR-ÄHNLICHES PROTEIN[2000/24]
English:HIGH AFFINITY IMMUNOGLOBULIN E RECEPTOR-LIKE PROTEIN[2000/24]
French:PROTEINE RESSEMBLANT AU RECEPTEUR DE L'IMMUNOGLOBULINE E DE HAUTE AFFINITE[2000/24]
Entry into regional phase28.02.2000National basic fee paid 
28.02.2000Designation fee(s) paid 
28.02.2000Examination fee paid 
Examination procedure12.03.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
28.02.2000Examination requested  [2000/24]
13.10.2004Despatch of a communication from the examining division (Time limit: M04)
25.01.2005Application withdrawn by applicant  [2005/11]
Fees paidRenewal fee
16.08.2000Renewal fee patent year 03
14.08.2001Renewal fee patent year 04
21.08.2002Renewal fee patent year 05
25.08.2003Renewal fee patent year 06
23.08.2004Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9321317  (US HEALTH [US]) [A] 1-13,17,18 * the whole document *
 [X]  - Emest7 Database Entry Hs1152201 Accession number AA234138; 6 March 1997 HILLIER L. ET AL.:"The WashU-Merck EST Project", XP002085473 [X] 1-13,17,18 * the whole document *
 [X]  - Emest8 Database Entry Hs1213902 Accession number AA418443; 14 May 1997 HILLIER L. ET AL.:"The WashU-Marck EST Project 1997", XP002085474 [X] 1-13,17,18 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.